{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:01:47Z","timestamp":1777532507376,"version":"3.51.4"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"name":"NIH","award":["P30 MH062261"],"award-info":[{"award-number":["P30 MH062261"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1093\/jac\/dkw403","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:59:02Z","timestamp":1474505942000},"page":"200-204","source":"Crossref","is-referenced-by-count":12,"title":["Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients"],"prefix":"10.1093","volume":"72","author":[{"given":"Uriel","family":"Sandkovsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T.","family":"Podany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney V.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Felton-Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee C.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Swindells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"2016121607301283000_72.1.200.1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31825a3668"},{"key":"2016121607301283000_72.1.200.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.02098.x"},{"key":"2016121607301283000_72.1.200.3","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0154"},{"key":"2016121607301283000_72.1.200.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2007.00473.x"},{"key":"2016121607301283000_72.1.200.5","doi-asserted-by":"crossref","unstructured":"Dickinson LJA , Garvey L , Watson V et al. Population pharmacokinetic modelling of plasma and intracellular once daily ritonavir-boosted darunavir in HIV-infected patients. In: Abstracts of the Twelfth International Workshop on Clinical Pharmacology of HIV Therapy, Miami, 2011. Abstract O12.","DOI":"10.1186\/1758-2652-13-S4-P184"},{"key":"2016121607301283000_72.1.200.6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061949"},{"key":"2016121607301283000_72.1.200.7","unstructured":"WHO. What's New in HIV Treatment. http:\/\/apps.who.int\/iris\/bitstream\/10665\/204347\/1\/WHO_HIV_2015.44_eng.pdf ."},{"key":"2016121607301283000_72.1.200.8","unstructured":"DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Department of Health and Human Services. https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf ."},{"key":"2016121607301283000_72.1.200.9","unstructured":"Sustiva Package Insert . Bristol-Myers Squibb, Princeton, NJ, USA. http:\/\/packageinserts.bms.com\/pi\/pi_sustiva.pdf ."},{"key":"2016121607301283000_72.1.200.10","doi-asserted-by":"publisher","DOI":"10.1310\/hct1006-343"},{"key":"2016121607301283000_72.1.200.11","first-page":"2391","article-title":"Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study","volume":"18","author":"Haas","year":"2004","journal-title":"AIDS"},{"key":"2016121607301283000_72.1.200.12","doi-asserted-by":"publisher","DOI":"10.1086\/499364"},{"key":"2016121607301283000_72.1.200.13","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.049601"},{"key":"2016121607301283000_72.1.200.14","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328328d577"},{"key":"2016121607301283000_72.1.200.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(01)00012-9"},{"key":"2016121607301283000_72.1.200.16","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr272"},{"key":"2016121607301283000_72.1.200.17","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.112.195701"},{"key":"2016121607301283000_72.1.200.18","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101050-00011"},{"key":"2016121607301283000_72.1.200.19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0090-9556(24)14935-5","article-title":"Identification and characterization of efavirenz metabolites by liquid chromatography\/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz","volume":"27","author":"Mutlib","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"2016121607301283000_72.1.200.20","unstructured":"Winchester L , Sandkovsky U , Fletcher CV et al . Quantification of efavirenz and its 7-hydroxy and 8-hydroxy metabolites in human plasma via LC\/MS\/MS. In: Abstracts of the Annual American Association of Pharmaceutical Scientists Meeting, Orlando, FL, 2015. Poster R6190. American Association of Pharmaceutical Scientists, Arlington, VA, USA."},{"key":"2016121607301283000_72.1.200.21","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu976"},{"key":"2016121607301283000_72.1.200.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04454.x"},{"key":"2016121607301283000_72.1.200.23","doi-asserted-by":"publisher","DOI":"10.1086\/380791"},{"key":"2016121607301283000_72.1.200.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103498"},{"key":"2016121607301283000_72.1.200.25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834171f8"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/1\/200\/8497285\/dkw403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T20:34:48Z","timestamp":1749587688000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1093\/jac\/dkw403"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw403","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]}}}